Guillen-Del Castillo, Alfredo <br/><br/>
Good outcome of interstitial lung disease in patients with scleroderma associated to anti-PM/Scl antibody.  [electronic resource] 

 -  Seminars in arthritis and rheumatism  Dec 2014 
 - 331-7 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Observational Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1532-866X 
<br/><br/><label>Standard No.: </label>10.1016/j.semarthrit.2014.07.002  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antibodies, Anti-Idiotypic--blood<br/>Biomarkers--blood<br/>Cohort Studies<br/>DNA Topoisomerases, Type I<br/>Exosome Multienzyme Ribonuclease Complex--immunology<br/>Female<br/>Humans<br/>Kaplan-Meier Estimate<br/>Lung<br/>Lung Diseases, Interstitial--diagnosis<br/>Male<br/>Middle Aged<br/>Nuclear Proteins--immunology<br/>Prognosis<br/>RNA-Binding Proteins--immunology<br/>Respiratory Function Tests<br/>Retrospective Studies<br/>Scleroderma, Systemic--complications<br/>Survival Rate